{
  "slug": "civica-rx",
  "name": "Civica Rx",
  "description": "Civica Rx is a not-for-profit pharmaceutical company established by hospitals to address generic medication shortages and high prices. It focuses on ensuring essential generic medications and biosimilars are available and affordable to all, operating on a 'patients, not profits' model. They manufacture medications in their U.S. facility and distribute to member hospitals and consumers.",
  "url": "https://optimly.ai/brand/civica-rx",
  "websiteUrl": null,
  "logoUrl": "https://logo.clearbit.com/https://civicarx.org/",
  "baiScore": 40,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Challenger",
  "archetype_status": "active",
  "category": "Healthcare",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-07-26T00:01:55.834Z",
  "verifiedVitals": {
    "website": "https://civicarx.org/",
    "founded": "2018",
    "pricing_model": "Not-for-profit, focused on affordability and stable, lower costs rather than market-driven profit maximization.",
    "core_products": "Essential generic injectables, generic medicines, biosimilars (e.g., vancomycin, abiraterone acetate, long-acting insulin glargine).",
    "key_differentiator": "Its not-for-profit model, being created by hospitals for hospitals, dedication to eliminating drug shortages, commitment to affordable pricing, and U.S.-based manufacturing facility.",
    "target_markets": "U.S. Hospitals (member hospitals), U.S. patients/consumers.",
    "subcategory": "Generic Drug Manufacturer"
  },
  "intentTags": {
    "problemIntents": [
      "Individual hospital negotiations: Hospitals and healthcare systems individually negotiate with multiple generic drug manufacturers and distributors, which can be less efficient and may not fully addre",
      "Group Purchasing Organizations (GPOs): Healthcare GPOs aggregate purchasing power for hospitals to secure better prices and supply, but may not directly intervene in manufacturing or specifically targ",
      "Maintain existing pharmaceutical market: Continuing with the current market dynamics where for-profit companies primarily drive production and pricing, potentially leading to ongoing drug shortages an"
    ],
    "solutionIntents": [
      "Civica Rx drug shortages",
      "Affordable generic medications Civica",
      "CivicaScript insulin price",
      "Governmental price regulation/intervention: Direct governmental policies or regulations to control drug prices or mandate supply levels for essential medications, which can be politically complex and "
    ],
    "evaluationIntents": []
  },
  "timestamp": 1785296338372
}